SIGIRR inhibits interleukin-1 receptor- and toll-like receptor 4-mediated signaling through different mechanisms
about
Regulatory Role of IL-1R8 in Immunity and DiseasePotential association between TLR4 and chitinase 3-like 1 (CHI3L1/YKL-40) signaling on colonic epithelial cells in inflammatory bowel disease and colitis-associated cancerModulation of Intestinal TLR4-Inflammatory Signaling Pathways by Probiotic Microorganisms: Lessons Learned from Lactobacillus jensenii TL2937Immunoregulatory Effects Triggered by Lactic Acid Bacteria Exopolysaccharides: New Insights into Molecular Interactions with Host CellsIL-37 requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transductionEvidence for a DC-specific inhibitory mechanism that depends on MyD88 and SIGIRRSecretory IgA in complex with Lactobacillus rhamnosus potentiates mucosal dendritic cell-mediated Treg cell differentiation via TLR regulatory proteins, RALDH2 and secretion of IL-10 and TGF-β.A central nervous system-restricted isoform of the interleukin-1 receptor accessory protein modulates neuronal responses to interleukin-1The essential role of single Ig IL-1 receptor-related molecule/Toll IL-1R8 in regulation of Th2 immune response.Association of Toll-like receptor signaling and reactive oxygen species: a potential therapeutic target for posttrauma acute lung injury.Hemorrhage-induced interleukin-1 receptor pathway in lung is suppressed by 3,5-bis(2-fluorobenzylidene)-4-piperidone in a rat model of hypovolemic shockThe receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activationGene expression profiling of microglia infected by a highly neurovirulent murine leukemia virus: implications for neuropathogenesisClinical features and outcome of patients with IRAK-4 and MyD88 deficiency.Altered expression of SHIP, a Toll-like receptor pathway inhibitor, is associated with the severity of liver fibrosis in chronic hepatitis C virus infectionTREM-1 amplifies corneal inflammation after Pseudomonas aeruginosa infection by modulating Toll-like receptor signaling and Th1/Th2-type immune responses.Role of Toll interleukin-1 receptor (IL-1R) 8, a negative regulator of IL-1R/Toll-like receptor signaling, in resistance to acute Pseudomonas aeruginosa lung infection.Common polymorphisms in the PKP3-SIGIRR-TMEM16J gene region are associated with susceptibility to tuberculosis.SIGIRR participates in negative regulation of LPS response and tolerance in human bladder epithelial cells.IL-1 family members in the pathogenesis and treatment of metabolic disease: Focus on adipose tissue inflammation and insulin resistanceA Structural View of Negative Regulation of the Toll-like Receptor-Mediated Inflammatory Pathway.Immunobiotic Lactobacillus jensenii modulates the Toll-like receptor 4-induced inflammatory response via negative regulation in porcine antigen-presenting cells.Toll-like receptor signaling and its relevance to intestinal inflammation.Suppression of TLR signaling by targeting TIR domain-containing proteinsGenetics of the innate immune response in inflammatory bowel disease.Tir8/Sigirr prevents murine lupus by suppressing the immunostimulatory effects of lupus autoantigens.Targeting toll-like receptors for drug development: a summary of commercial approaches.Decoys and Regulatory "Receptors" of the IL-1/Toll-Like Receptor Superfamily.Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease.Regulation of toll-like receptors in intestinal epithelial cells by stress and Toxoplasma gondii infectionSuppression of innate inflammation and immunity by interleukin-37.Expression of the NF-kappaB inhibitor ABIN-3 in response to TNF and toll-like receptor 4 stimulation is itself regulated by NF-kappaB.Novel pharmacologic approaches to the management of sepsis: targeting the host inflammatory response.Pattern recognition receptor-dependent mechanisms of acute lung injury.Human Colon Tumors Express a Dominant-Negative Form of SIGIRR That Promotes Inflammation and Colitis-Associated Colon Cancer in Mice.Epithelium: the interplay between innate and Th2 immunity.Role of Toll-like receptor-4 in renal graft ischemia-reperfusion injury.Innate immunity signaling pathways: links between immunonutrition and responses to sepsis.SIGIRR, a negative regulator of colon tumorigenesis.Toll-like Receptors in Chronic Lymphocytic Leukemia.
P2860
Q26752524-76C2AB09-AB5C-4F4D-9EA2-A45FBC6F68B6Q26853189-1D1A22D0-141F-4039-B14B-D55A27F37CEAQ26992250-126BCC36-BA78-47E0-8DB2-968E5B851B7AQ28078715-AA93F0C4-B472-4755-8A14-4D6941ED108FQ28258076-287CB14A-6B80-4C5C-825F-AAAD042C9B2EQ33884220-AED2B361-2CD2-4C86-BB87-39362E51B31DQ33920126-C4649863-4B3E-4525-8917-257F42B7D8A6Q33921027-7AB4CCC2-9660-4ADD-9594-8E7E5E2020FCQ33936725-E78BF104-F140-4159-A0C9-331495130CEDQ34035581-7ABE30EA-F5F3-44B7-A53C-B2C3E8518E0CQ34097843-EFBADE7B-774A-4103-A707-48F400D36ECFQ34462752-CC96E428-C0D8-4815-8769-F42ECED13BF4Q34666321-BBA3CAAF-EFF5-4488-9700-709BC172F128Q35012945-07D1788F-23A8-4EF1-B17E-0A963C75F4E2Q35214136-17865465-8E6B-4E15-AF15-C0684F49AAE2Q35328809-0E190FCC-06E1-4FC1-8F67-9525D6FA05A7Q35665349-AE690F5B-054D-4DEA-9368-6370E59A7409Q35694701-90E88020-E3B9-4421-BCB8-7279FD03266FQ35860382-76FC313B-259D-4585-B746-E0E4879B20E0Q36005876-49E30186-29A8-4BD0-B156-CB80232C1A0BQ36076152-7136DAFA-01C5-4DF8-837D-B9E64D295977Q36086232-845FEDF4-4F8C-4701-9826-35448FD3F8C3Q36631499-6933DB4D-3898-444D-AD8A-066EF8BC00EFQ36676056-491C0926-1BB2-49A0-8E84-6075298A11D9Q36700670-76483B95-3E20-4E9B-B2E8-E48CCF5278A3Q36851869-1A7E3563-ABF1-4676-B42F-5360184C3ABAQ36898653-5021EF1B-2E74-4701-8D5C-AFB944924A40Q36994635-5BE5549A-1ED6-4564-B38D-680E6D8BC6CEQ36994761-1B1C9B8E-F9DE-46FF-B159-DB2CA67703BAQ37013088-DDD88BE5-213C-4943-9F58-97A0C39F3D75Q37213297-EA464F41-1F0A-49C7-B171-3FAB51CAF257Q37296391-4E55419D-0AFA-495E-A555-B2C1F111F03BQ37367885-779B43C0-0F36-47DB-893E-832EF1436DE3Q37447260-6BC62FC7-D38C-46D6-9BF8-97B6AC879956Q37641275-13080BEB-8609-4F32-8122-56C3A3A90840Q37672258-03497620-E5A1-4CFC-A70A-0846028674A8Q37707474-860D20B4-06EB-43E6-9E32-420DB2A7DDECQ37836563-2B0C7655-BFCE-4A73-B50B-B234582E339BQ38005124-2CE3ABCE-04CE-4437-9DA5-A648431E5EC0Q38042942-385EF739-AFDA-4ED4-8F41-17F3B37DA427
P2860
SIGIRR inhibits interleukin-1 receptor- and toll-like receptor 4-mediated signaling through different mechanisms
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
SIGIRR inhibits interleukin-1 ...... g through different mechanisms
@ast
SIGIRR inhibits interleukin-1 ...... g through different mechanisms
@en
SIGIRR inhibits interleukin-1 ...... g through different mechanisms
@en-gb
SIGIRR inhibits interleukin-1 ...... g through different mechanisms
@nl
type
label
SIGIRR inhibits interleukin-1 ...... g through different mechanisms
@ast
SIGIRR inhibits interleukin-1 ...... g through different mechanisms
@en
SIGIRR inhibits interleukin-1 ...... g through different mechanisms
@en-gb
SIGIRR inhibits interleukin-1 ...... g through different mechanisms
@nl
prefLabel
SIGIRR inhibits interleukin-1 ...... g through different mechanisms
@ast
SIGIRR inhibits interleukin-1 ...... g through different mechanisms
@en
SIGIRR inhibits interleukin-1 ...... g through different mechanisms
@en-gb
SIGIRR inhibits interleukin-1 ...... g through different mechanisms
@nl
P2093
P2860
P921
P3181
P356
P1476
SIGIRR inhibits interleukin-1 ...... g through different mechanisms
@en
P2093
Jianhong Yao
Jinzhong Qin
Xiaoxia Li
Youcun Qian
P2860
P304
P3181
P356
10.1074/JBC.M501363200
P407
P577
2005-07-01T00:00:00Z